The purpose of this study is to collect blood samples to test, improve, and further develop a suite of cell-free DNA screening tests used during pregnancy. Pregnant individuals carrying a single baby, between 10 and 16 weeks along, who have had an abnormal prenatal screening (NIPT) are needed at this stage of research.